Wakefield computing start-up secures £3m in angel investment

Optalysys, the Wakefield and US-based start-up focussed on light-speed optical coprocessors, has secured £3.05 million from undisclosed angel investors.

The start-up will used the funds to manufacture the first commercially available high-performance computing (HPC) processor based on its patented optical processing technology.

CEO Dr Nick New said:

“In many industries today, the demand for faster processing far exceeds the capabilities of conventional computing technology.

“Until now, only large universities and organizations have the means to use this kind of computing muscle.

“Our aim is to make supercomputing levels of processing power accessible to a much wider audience of scientists and researchers – which will promote more rapid advancement in such fields as precision medicine and machine learning, whilst at the same time addressing some of the fundamental limitations of conventional computing.”

Because its coprocessor excels at rapid and accurate pattern recognition (required for Big Data processing) and mathematical model generation applications, genomic sequence alignment is the first of many application areas targeted by Optalysys.

Last month, the company demonstrated its latest prototype for genomic searching.

“Our prototype is on track to achieve game-changing improvements to process times over current methods whilst providing levels of accuracy that are associated with the best software processes.” said Emma Blaylock, Director and Chief Commercial Officer at Optalysys.